BioGene Technology【BGT】銘柄情報

BioGene Technology Ltd (BGT) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.02

( - )

買値

0.019

売値

0.024

出来高

823,943

0.02 日の範囲 0.02

0.016 52 週間の範囲 0.061

時価総額

6.101M

前日終値

0.02

始値

0.02

時刻

5917

0.02

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

AUD 344,035

発行済株式数

305,061,108

配当利回り

PER

-2.09

1 株当たり利益 (EPS)

-0.01

歳入

純利益

-2.52M

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-deri... Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activity of its molecules against a range of insect species; Advanced Molecular Technologies; CSIRO for a chemistry development process; the Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University for chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications, as well as insect management in crop protection. The company was incorporated in 1995 and is based in Melbourne, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.bio-gene.com.au

本社

Melbourne, Australia

設立

1995

BioGene Technology Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker BGT. The last closing price for BioGene Technology was AUD0.02. Over the last year, BioGene Technology shares have traded in a share price range of AUD 0.016 to AUD 0.061.

BioGene Technology currently has 305,061,108 shares in issue. The market capitalisation of BioGene Technology is AUD6.10 million. BioGene Technology has a price to earnings ratio (PE ratio) of -2.09.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.02	0.021	0.019	531767	0.01963999	DE
4	-0.009	-31.0344827586	0.029	0.03	0.019	633979	0.0211551	DE
12	-0.013	-39.3939393939	0.033	0.04	0.019	360559	0.02429637	DE
26	-0.003	-13.0434782609	0.023	0.045	0.019	252561	0.02675374	DE
52	0.004	25	0.016	0.061	0.016	361756	0.03028719	DE
156	-0.06	-75	0.08	0.105	0.016	264655	0.03931164	DE
260	-0.165	-89.1891891892	0.185	0.35	0.016	231706	0.09326949	DE